Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Axelle Maulet"'
Autor:
Nicolas Merienne, Gabriel Vachey, Lucie de Longprez, Cécile Meunier, Virginie Zimmer, Guillaume Perriard, Mathieu Canales, Amandine Mathias, Lucas Herrgott, Tim Beltraminelli, Axelle Maulet, Thomas Dequesne, Catherine Pythoud, Maria Rey, Luc Pellerin, Emmanuel Brouillet, Anselme L. Perrier, Renaud du Pasquier, Nicole Déglon
Publikováno v:
Cell Reports, Vol 20, Iss 12, Pp 2980-2991 (2017)
Neurodegenerative disorders are a major public health problem because of the high frequency of these diseases. Genome editing with the CRISPR/Cas9 system is making it possible to modify the sequence of genes linked to these disorders. We designed the
Externí odkaz:
https://doaj.org/article/c95c2641b9a34acb9503af6deab5c2eb
Autor:
Laurent Kiger, L. Joseph, Axelle Maulet, Aurélie Gabrion, Annarita Miccio, Ambroise Marçais, Marina Cavazzana, Olivia Leblanc, Anne Chalumeau, Michaela Semeraro, Jean-Marc Tréluyer, Alessandra Magnani, Olivier Hermine, Pablo Bartolucci, Felipe Suarez, Elisa Magrin, Valérie Jolaine, Cécile Roudaut, Nicolas Hebert, Emmanuelle Six, Wassim El Nemer, Jouda Marouene, Fulvio Mavilio
Publikováno v:
Blood. 138:1854-1854
In sickle cell disease (SCD), the β6 Glu→Val substitution leads to sickle hemoglobin (HbS) polymerization and red blood cell (RBC) sickling. Transplantation of autologous, genetically modified hematopoietic stem/progenitor cells (HSPCs) represents
Autor:
Nicolas Merienne, Gabriel Vachey, Lucie de Longprez, Cécile Meunier, Virginie Zimmer, Guillaume Perriard, Mathieu Canales, Amandine Mathias, Lucas Herrgott, Tim Beltraminelli, Axelle Maulet, Thomas Dequesne, Catherine Pythoud, Maria Rey, Luc Pellerin, Emmanuel Brouillet, Anselme L. Perrier, Renaud du Pasquier, Nicole Déglon
Publikováno v:
Cell reports, vol. 20, no. 12, pp. 2980-2991
Cell Reports, Vol 20, Iss 12, Pp 2980-2991 (2017)
Cell Reports, Vol 20, Iss 12, Pp 2980-2991 (2017)
Neurodegenerative disorders are a major public health problem because of the high frequency of these diseases. Genome editing with the CRISPR/Cas9 system is making it possible to modify the sequence of genes linked to these disorders. We designed the